A funding boost of more than £78 million will help scientists working to develop a potential treatment for motor neurone disease. Amyotrophic lateral sclerosis (ALS) is the most common form of ...
A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...
A drug that can dramatically delay the progress of motor neurone disease (MND) will not be made available on the NHS because not enough people can benefit from it. Studies show that tofersen is ...
Today the victim of motor neurone disease, he hasn't the strength to open a packet of crisps. Here he tells how his life has changed beyond recognition in less than a year. Eight months ago I ...
Kinlough native Maeve Kilgannon who was diagnosed with Motor Neurone disease two years ago is raising money for IMNDA Maeve Kilgannon at her home in Kinlough, Co Leitrim. Pic: Donal Hackett.
Trace Neuroscience, a UCL spinout biopharmaceutical company, has received $101m (£78m) in Series A funding, to help develop potential treatments for the most common form of motor neurone disease. In ...
Pathological abnormalities associated with motor neurone disease have been identified using a new technique developed at the University of Birmingham. Research into the life-shortening ...